Dragon Dictation is an easy-to-use voice recognition application powered by Dragon® NaturallySpeaking® that allows you to easily speak and instantly see your text or email messages. In fact, it’s up to five (5) times faster than typing on the keyboard. Features: Voice-to-text transcriptions that may be sent as SMS, Email, …

A 43-year old patient with a 2-year history of type 2 diabetes presents to your office for a follow-up visit. She is a highly motivated patient and doesn’t have any significant co-morbidities, so together, you have set a target A1C= 6.5%. Her current medications are metformin and sulfonylurea. Despite her good efforts, her current A1C is 7.3%. You would like to add a third agent to her regimen, however she is concerned about any additional weight gain as she has gained a few pounds since starting the sulfonylurea. Which drug class would you add to minimize any additional weight gain? A. Basal insulin B. GLP-1 agonist C. Thiazolidine D. DPP-4 Inhibitor Follow link to take the test!

Incidence of type 2 diabetes is increasing rapidly. It accounts for up to half of all cases of new-onset diabetes in young people. Dysfunction in glucose homeostasis impacts acid-base regulation. In addition, injury to organs as a result of diabetes and antidiabetic drugs contribute to this dysregulation. Hyponatremia is associated …

Unilife Corporation has launched the world’s first instant insulin patch, Imperium. Imperium is a prefilled, preassembled, multi-day wearable insulin pump for continuous subcutaneous insulin infusion and on-demand bolus delivery through the push of a button. It is equipped with Bluetooth connectivity to wirelessly connect with smartphone apps for patient reminders …

The Diabetes Research Institute (DRI), a Center of Excellence at the University of Miami Miller School of Medicine, announced today that the first patient in its clinical trial has been free from insulin injections in record time following the implantation of islet cells within a biological scaffold. The patient, Wendy …

Patients with diabetes have to monitor their blood glucose at home until the next doctor’s appointment. Smart blood glucose meter provides patients with easy access to certified diabetes educator and avoid future diabetes complications, according to Jodi Pulizzi, RN, BSN, CDE, CHC, director of clinical services for Livongo Health, based …

Consuming more salt, regardless of caloric consumption, can lead to obesity or being overweight. A study in the journal Hypertension reports that an increased intake of 1 g of sodium per day increases the risk of obesity by 28% in children and 26% in adults. In the UK and the …

Research was recently published inDiabetes Care as a Phase II study to determine optimal dosing, tolerability and efficacy of a new, once-weekly DPP-4 inhibitor called omarigliptin. Over 12 weeks, the researchers looked at HbA1C, 2-hour postprandial glucose and fasting glucose. Currently, the DPP-4 inhibitors on the market are all once-daily. …

Thiazolidinediones (TZDs), rosiglitazone and pioglitazone, have been shown to increase fracture risk in women after a year of TZD use; however, there has been little data available on the effects of the discontinuation of TZD. This longitudinal observational cohort study used data from an ancillary study of skeletal health within …

Mineralocorticoid receptor antagonists (MRAs) are often used with a renin-angiotensin system (RAS) blocker to further reduce proteinuria in patients with CKD. However, eplerenone and spironolactone increase the risk of hyperkalemia in these patients. Finerenone (BAY94-8862) is a new nonsteroidal MRA that has better receptor selectivity than spironolactone, associating with lower …